Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
New blood treatment could save trauma patients faster
Disease control Not yet recruitingThis study tests whether a new, shelf-stable blood product (IFC) can treat severe bleeding in injured patients faster than the standard product (Cryo-AHF). About 320 adults with traumatic injuries and low fibrinogen levels will receive one of the two treatments. The goal is to se…
Sponsor: Cerus Corporation • Aim: Disease control
Last updated May 17, 2026 07:39 UTC
-
Will Pre-Existing antibodies make blood transfusions risky? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether people who already have antibodies to INTERCEPT-treated red blood cells (a type of blood product) might have a stronger immune reaction or faster breakdown of the transfused blood. Ten participants, including some with and some without these antibodies…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC